Biopharmaceutical Development Team

The Biopharmaceutical Development Team at Molecular Templates is responsible for advancing the company's proprietary engineered toxin bodies (ETBs) from preclinical stages through clinical development. This includes optimizing protein sciences, ensuring robust CMC (Chemistry, Manufacturing, and Controls) processes, and translating preclinical findings into clinical strategies to effectively treat cancer.